Dubberke, ER, Reske, KA, Olsen, MA, McDonald, LC, Fraser, VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis
Dubberke, ER, Butler, AM, Reske, KA, et al.
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis
Kyne, L, Hamel, MB, Polavaram, R, Kelly, CR
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
. Clin Infect Dis
Loo, VG, Libman, MD, Miller, MA, et al.
Clostridium difficile: a formidable foe. CMAJ
Loo, VG, Poirier, L, Miller, MA, et al.
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med
Muto, CA, Pokrywka, M, Shutt, K, et al.
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol
Pépin, J, Valiquette, L, Alary, M-E, et al.
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003; a changing pattern of disease severity. CMAJ
Pépin, J, Alary, M-E, Valiquette, L, et al.
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis
Pépin, J, Valiquette, L, Cossette, B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ
Dial, S, Alrasadi, K, Manoukian, C, Huang, A, Menzies, D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ
Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA
Dial, S, Delaney, JA, Schneider, V, Suissa, S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ
Dubberke, ER, Reske, KA, Olsen, MA, et al.
Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med
Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ.
Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis
Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr.
Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol
Kyne, L, Sougioultzis, S, McFarland, LV, Kelly, CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol
Pépin, J, Saheb, N, Coulombe, M-A, et al.
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis
McDonald, LC, Owings, M, Jernigan, DB.
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis
Muto, CA, Blank, MK, Marsh, JW, et al.
Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis
Peterson, CA, Calderon, RL. Trends in enteric disease as a cause of death in the United States, 1989-1996. Am J Epidemiol
Johnson, S, Gerding, DN, Olson, MM, et al.
Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med
Kaatz, GW, Gitlin, SD, Schaberg, DR, et al.
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol
Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile
. Clin Infect Dis
McMullen, KM, Zack, J, Coopersmith, CM, Kallef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol
D'Agostino, RB, Belanger, AJ, Markson, EW, Kelly-Hayes, M, Wolf, PA. Development of health risk appraisal functions in the presence of multiple indicators: the Framingham Study nursing home institutionalization model. Stat Med
Harrell, FE Jr, Margolis, PA, Gove, S, et al.
Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological Agents of Pneumonia, Sepsis and Meningitis in Young Infants. Stat Med
Garey, KW, Dao-Tran, TK, Jiang, ZD, Price, MP, Gentry, LO, DuPont, HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect
Tanner, J, Khan, D, Anthony, D, Paton, J. Waterlow score to predict patients at risk of developing Clostridium difficile-associated disease. J Hosp Infect
Thorn, KA, Shardell, MD, Osih, RB, et al.
Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points. Infect Control Hosp Epidemiol
D'Agostino, RB, Griffith, JL, Schmidt, CH, Terrin, N. Measures for evaluating model performance. In: Proceedings of the Biometrics Section. Alexandria, VA: American Statistical Association, 1997:253–258.
Cook, NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem
Efron, B, Tibshirani, R. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
Bilgrami, S, Feingold, JM, Dorsky, D, et al.
Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant
Chakrabarti, S, Lees, A, Jones, SG, Milligan, DW.
Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant
Tomblyn, M, Gordon, L, Singhai, S, et al.
Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone Marrow Transplant
Yuen, K-Y, Woo, PCY, Liang, RHS, et al.
Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbiol Infect Dis
Dubberke, ER, Gerding, DN, Classen, D, et al.
Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol